Amyotrophic lateral sclerosis (ALS) shows complex inheritance. A new meta-analysis of three data sets has replicated previous estimates of the heritability attributable to common genetic variation, corroborated some previously identified disease-associated genetic loci, and suggested novel loci. Despite such efforts, our understanding of the genetic architecture of ALS remains limited.
In any one person, amyotrophic lateral scler osis (ALS) can be caused by environmental factors acting in concert with a single gene (monogenic), a few genes (oligogenic), or several genes (polygenic). This complexity in the genetic architecture of ALS has pro found implications for genetic counselling and other information given to patients. One measure of the degree to which genetic vari ation influences the risk of a disease is her itability (Box 1). In a new study published in JAMA Neurology, Margaux Keller and colleagues 1 have performed a metaanalysis of three previously published genomewide association studies (GWAS) comprising 1,223 patients with ALS and 1,591 controls. Keller et al. reported a heritability estimate for ALS using a method called GREML, which is implemented in the GenomeWide Complex Trait Analysis software package. 2 An estimate of heritability is important to assess whether genetic variation influences the risk of ALS in people with no apparent family history. Evidence for such an influ ence has come from various sources, includ ing the risk of ALS in relatives, 3 heritability estimates from pedigree data 4, 5 and from unrelated individuals using single nucleo tide polymorphism (SNP) data, 6 oligo genic and Mendelian mimics of sporadic ALS, 7, 8 statistical models, 9 consistency of diagnosis of familiality, 10 and the finding of Mendelian ALSrelated genes in individu als with apparently sporadic ALS, as collated by Amyotrophic Lateral Sclerosis Online Genetics Database. Quantification and dis section of heritability enables us to counsel patients effectively and to know where to focus our research efforts-in the context of GWAS, heritability quantifies the contribu tion of variation from common SNPs that can be identified using larger experimental sample sizes.
Keller and colleagues report heritability of ALS as 21%, and contrast this figure with the result from an earlier study that reported an estimate of 12% from a larger set of 6,100 sporadic cases and 7,125 controls, which partly overlaps with the current study and used identical methods. 6 These estimates can be reconciled by noting that, in addi tion to sampling variation, the two studies used different prevalences: 10 per 100,000 persons for the study by Keller et al., and 5 per 100,000 for the earlier study. Indeed, the earlier study also estimated heritabil ity of liability as 21% at a prevalence of 10 per 100,000.
It is important to clarify that what Keller and colleagues report is not in fact the her itability of ALS but, rather, the heritability of ALS that is captured by considering all common SNP variants simultaneously. ALS heritability estimates from twin studies are 76% (95% CI 60-86%) when all cases are included and 61% (95% CI 38-78%) when familial cases are excluded, 4 and in family studies they range from 40-60%: 5 the twin and family studies estimate the total herit ability, of which part is due to common SNP variants. The remaining 'hidden' heritability is likely to be found in rare variants and other genetic variations, such as copy number vari ants that are not captured by common SNP analysis. When heritability is estimated from pedigree data (for example, in a twin study), it is blind with respect to the allelic spectrum of causal variants in the population. By con trast, heritability estimated from SNP data (as in the Keller et al. study) depends on the underlying genetic architecture. The con tribution of low frequency-say, less than 1 in 1,000-variants will not be captured from GWAS data, but will be captured in a pedigree study.
Keller and collaborators used samples from three groups: people with apparently sporadic ALS from a genetically hetero geneous Italian population, people with familial or sporadic ALS from a speciality clinic in Finland (a genetically relatively homogeneous population), and people from speciality clinics based in the USA. 1 One might expect the heritability estimate to differ between familial and sporadic samples, and in this regard it is interesting
Box 1 | What is heritability?
Heritability does not mean 'genetic contribution'. Heritability refers to the proportion of phenotypic variance that is explained by genetic variance, and can be estimated using different experimental designs, whereas genetic contribution refers to the extent to which a trait is genetically determined. For example, the heritability of having a head is zero, because there is no phenotypic variance (everyone has a head), even though having a head is clearly completely genetically determined.
Heritability applies to populations, not individuals. Knowing the heritability of amyotrophic lateral sclerosis (ALS) tells us nothing about the genetic contribution to disease in an individual, or in a population of different ethnicity.
For a quantitative trait, such as height, the phenotypic variance can be estimated from a population sample. For a discrete trait, such as ALS, geneticists assume an underlying liability to disease that has a normal distribution and includes genetic and environmental components; only individuals carrying enough liability develop disease. Variation in observed risk reflects population prevalence, and is related to heritability on the risk scale.
to note that the heritability seemed the same in all three cohorts. This finding underlines previous work showing that the distinc tion between familial and sporadic cases is ambiguous, because clinicians are not uniform in their definitions, 10 the probabil ity of more than one person being affected depends on family size and penetrance, 9 and the relatives of those with sporadic ALS have an increased risk of the disease, prob ably because of oligo genic and polygenic effects. 3, 8 The finding is also consistent with twin studies that show little change in heritability estimates with the inclusion or exclusion of familial samples. 4, 5 A key and novel finding reported by Keller and colleagues is that of genomic regions explaining a significant proportion of vari ation and, therefore, possibly harbouring ALSrelated genes. The authors used 20 Mb segments of the genome and applied GREML methods to each segment in each popula tion, with regions of interest then broken down into 1 Mb regions for further analysis. 2 The results were then metaanalysed across the three populations. This is an interest ing strategy, and an alternative to standard association testing using individual SNPs, but requires care in interpretation, because 20 Mb regions can soak up variation from nearby regions due to linkage disequilibrium.
The study by Keller et al. replicates previ ous work on ALS heritability captured from common SNPs and confirms existing ideas about the role of genetic variation in appar ently sporadic ALS. 6 The estimates from the current and previous studies are consistent, and point to a role for common variants in ALS. The heritability explained by the few loci identified in GWAS to date is less than 1%, implying that many more common loci are still to be found, and that these can be detected when larger experimental sample sizes are used.
Our understanding of the genetic architec ture of ALS has been transformed in recent years by advances in genetic technologies, statistical and computing approaches to genetics, and our knowledge of the genome. Clinicians might find it difficult to keep up with such a rapidly changing field, but the message to our patients must remain based in evidence and be consistent: ALS has a genetic component, but it varies in degree between people; the risk to relatives of someone with no family history remains small; and until effective therapies are available, genetic testing of affected individuals with no family history should only be undertaken after very careful consideration of the consequences.
